Shufro Rose & Co’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-258,800
Closed -$525K 284
2016
Q1
$525K Sell
258,800
-1,600
-0.6% -$2.85K 0.06% 158
2015
Q4
$645K Sell
260,400
-2,566
-1% -$7.61K 0.07% 142
2015
Q3
$683K Sell
262,966
-11,534
-4% -$30.1K 0.08% 138
2015
Q2
$861K Buy
274,500
+15,500
+6% +$53.1K 0.09% 127
2015
Q1
$740K Buy
259,000
+182,700
+239% +$467K 0.08% 143
2014
Q4
$196K Sell
76,300
-44,200
-37% -$193K 0.02% 235
2014
Q3
$898K Buy
120,500
+7,500
+7% +$70.1K 0.09% 126
2014
Q2
$1.33M Buy
113,000
+14,900
+15% +$159K 0.14% 100
2014
Q1
$1.14M Buy
98,100
+4,100
+4% +$48.2K 0.12% 104
2013
Q4
$1.02M Buy
94,000
+57,000
+154% +$561K 0.11% 107
2013
Q3
$399K Hold
37,000
0.05% 169
2013
Q2
$433K Buy
+37,000
New +$370K 0.05% 159

Shufro Rose & Co's SZYM Position: Q2 2016 in Review

Shufro Rose & Co sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 258,800 shares — an estimated $525K sold.

Shufro Rose & Co first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $1.33M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Shufro Rose & Co reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Shufro Rose & Co sold 258,800 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $525K.
  • Shufro Rose & Co first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Shufro Rose & Co's SOLAZYME INC COM STK (DE) position peaked at $1.33M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Shufro Rose & Co's 13F filing for Q2 2016, filed 5 Aug 2016.